Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Course of Alefacept in Chronic Plaque Psoriasis
NCT00794807Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2004
- Primary completion
- Dec 2005
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of alefacept in psoriasis, sponsored by Charité – Universitätsmedizin Berlin. Started Feb 2004; status: completed.
02
Drugs
alefacept
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00794807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794807.